Cargando…

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) is prevalent, with a dramatic increase in recent years. Moreover, its microvascular and macrovascular complications cause significant societal issues. The demand for new and effective antidiabetic therapies grows with each passing day and motivates organizations and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wei, Huang, Wen, Xu, Zhiqiang, Cao, Mengda, Hu, Qiaoli, Pan, Chen, Guo, Miao, Wei, Ji-Fu, Yuan, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556973/ https://www.ncbi.nlm.nih.gov/pubmed/31214029 http://dx.doi.org/10.3389/fphar.2019.00586

Ejemplares similares

What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China
por: Liu, Shimeng, et al.
Publicado: (2021)

Antihyperglycemic activity of Albizzia lebbeck bark extract in streptozotocin-nicotinamide induced type II diabetes mellitus rats
por: Patel, Priyank A., et al.
Publicado: (2015)

Antihyperglycemic and Antihyperlipidemic Effects of Aqueous Extracts of Lannea edulis in Alloxan-Induced Diabetic Rats
por: Banda, Michelo, et al.
Publicado: (2018)

Antihyperglycemic and antioxidant activity of Clitorea ternatea Linn. on streptozotocin-induced diabetic rats
por: Talpate, Karuna A., et al.
Publicado: (2013)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
por: Zhuang, Wei, et al.
Publicado: (2020)

Chemical Composition, Antioxidant and Antihyperglycemic Activities of the Wild Lactarius deliciosus from China
por: Xu, Zhou, et al.
Publicado: (2019)

Hypoglycemic and antihyperglycemic activity of Saptarangyadi Ghanavati: An Ayurvedic compound formulation
por: Singh, Kanwar Samrat, et al.
Publicado: (2014)

Antihyperglycemic effect of thymoquinone and oleuropein, on streptozotocin-induced diabetes mellitus in experimental animals
por: Sangi, Sibghatullah Muhammad Ali, et al.
Publicado: (2015)

A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Zhang, Nan, et al.
Publicado: (2020)

Tibetan Medicine for Diabetes Mellitus: Overview of Pharmacological Perspectives
por: Yan, Li-Shan, et al.
Publicado: (2021)

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
por: Hauber, A. Brett, et al.
Publicado: (2015)

Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Frontiers Production Office,
Publicado: (2021)

FGF4, A New Potential Regulator in Gestational Diabetes Mellitus
por: Fan, Miaojuan, et al.
Publicado: (2022)

Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis
por: Barcina Lacosta, Teresa, et al.
Publicado: (2022)

Efficacy and Safety of Oral Acetaminophen for Premature Infants With Patent Ductus Arteriosus: A Meta-Analysis
por: Zi-Yun, Xie, et al.
Publicado: (2022)

Intervention of Gastrodin in Type 2 Diabetes Mellitus and Its Mechanism
por: Bai, Yu, et al.
Publicado: (2021)

Biosimilar monoclonal antibodies in China: A patent review
por: Liu, Jia-Wei, et al.
Publicado: (2022)

Comparative clinical-related outcomes of Chinese patent medicines for cardiac hypertrophy: A systematic review and network meta-analysis of randomized clinical trials
por: Zhang, Tianqi, et al.
Publicado: (2023)

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
por: Milonas, Dimitrios, et al.
Publicado: (2019)

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
por: Nargesi, Arash A., et al.
Publicado: (2021)

Bladder Dysfunction in Diabetes Mellitus
por: Golbidi, Saeid, et al.
Publicado: (2010)

Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review
por: Li, Weiwei, et al.
Publicado: (2017)

Rhein for treating diabetes mellitus: A pharmacological and mechanistic overview
por: Deng, Tingting, et al.
Publicado: (2023)

A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2021)

Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era
por: Xu, Mengda, et al.
Publicado: (2021)

Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era
por: Xu, Mengda, et al.
Publicado: (2023)

Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
por: Mucke, Hermann A. M.
Publicado: (2017)

The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
por: Jiang, Ya-yi, et al.
Publicado: (2020)

Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
por: Lin, Shu Ning, et al.
Publicado: (2020)

The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
por: Zhang, Zehua, et al.
Publicado: (2022)

Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017)

The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine
por: Ma, Xueling, et al.
Publicado: (2018)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021)

Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
por: Tang, Wai Ho, et al.
Publicado: (2012)

Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
por: He, Yumei, et al.
Publicado: (2023)

An Efficacy and Feasibility Analysis of Chinese Patent Medicine Combined With Letrozole in the Treatment of Women With Ovulation Disorders: A Network Meta-Analysis
por: Zhu, Jing-Yan, et al.
Publicado: (2021)

Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents
por: Yang, Hong, et al.
Publicado: (2017)

Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_87fbd9u5g3niuae6efi2hvjp4i